Cetrorelix in an oral contraceptive-pretreated stimulation cycle compared with buserelin in IVF/ICSI patients treated with r-hFSH: A randomized, multicentre, phase IIIb study

Human Reproduction

Volumn 21, Issue 6, 2006, Pages 1408-1415

  Huirne, J A ^a   Hugues, J N ^b   Pirard, C ^c   Fischl, F ^d   Sage, J C ^e   Pouly, J L ^f   Obruca, A ^g   Braat, D M ^h   van Loenen, A C D ^a   Lambalk, C B ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITÉ PARIS 13   (France)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^d UNIVERSITY OF VIENNA   (Austria)

^e Tour Belledonne   (France)

^f HÔTEL DIEU   (France)

^g Kinderwunschzentrum Wien   (Austria)

^h RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

GnRH agonist; GnRH antagonist; IVF; Oral contraceptive; Programming

Indexed keywords

BUSERELIN; CETRORELIX; ETHINYLESTRADIOL PLUS LEVONORGESTREL; PROGESTERONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ABDOMINAL DISCOMFORT; ABDOMINAL DISTENSION; ABDOMINAL PAIN; ABNORMAL DREAMING; ADULT; AGGRESSION; ARTHRALGIA; ARTICLE; BACKACHE; BREAST DISEASE; BREAST HYPERTROPHY; BREAST TENDERNESS; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYING; DEPRESSION; DIZZINESS; DOWN REGULATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EAR DISEASE; ECTOPIC PREGNANCY; EMBRYO TRANSFER; EYE DISEASE; FATIGUE; FEMALE; FERTILIZATION IN VITRO; GASTROINTESTINAL DISEASE; GYNECOLOGIC DISEASE; HEADACHE; HUMAN; IMMUNOPATHOLOGY; INFECTION; INFERTILITY; INJECTION SITE CONTUSION; INJECTION SITE PRURITUS; INTRACYTOPLASMIC SPERM INJECTION; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MAXIMUM PERMISSIBLE DOSE; MENTAL DISEASE; MOOD CHANGE; MULTICENTER STUDY; MUSCULOSKELETAL DISEASE; NAUSEA; NEUROLOGIC DISEASE; OVARY CYST; OVARY HYPERSTIMULATION; OVARY HYPERTROPHY; OVULATION INDUCTION; PHASE 3 CLINICAL TRIAL; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SIDE EFFECT; SLEEP DISORDER; VASCULAR DISEASE;

EID: 33747070658     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del030     Document Type: Article

References (21)

1. Albano C, Felberbaum RE, Smitz J, Riethmuller-Winzen H, Engel J, Diedrich K, Devroey P and The European Cetrorelix Study Group (2000) Ovarian stimulation with HMG: Results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. Hum Reprod 15,526-531.
2. Al-Inany H and Aboulghar M (2002) GnRH antagonist in assisted reproduction: A Cochrane review. Hum Reprod 17,874-885.
3. Barmat LI, Chantilis SJ, Hurst BS and Dickey RP (2005) A randomised prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pre-treated with oral contraceptives before in vitro fertilization. Fertil Steril 83,321-330.
4. Borm G and Mannaerts B (2000) Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: Results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. Hum Reprod 15,1490-1498.
5. de Ziegler D, Jaaskelainen AS, Brioschi PA, Fanchin R and Bulletti C (1998) Synchronization of endogenous and exogenous FSH stimuli in controlled ovarian hyperstimulation (COH). Hum Reprod 13,561-564.
6. European and Middle East Orgalutran Study Group (2001) Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod 16,644-651.
7. Fanchin R, Salomon L, Caselo-Branco A, Olivennes F, Frydman N and Frydman R (2003) Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists. Hum Reprod 18,2698-2703.
8. Fluker M, Grifo J, Leader A, Levy M, Meldrum D, Muasher SJ, Rinehart J, Rosenwaks Z, Scott RT Jr, Schoolcraft W et al. (2001) Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil Steril 75,38-45.
9. Huirne AF, Van Loenen ACD, Donnez J, Pirard C, Homburg R, Schats R, McDonnell J, Lambalk CB (in press) Follicular development in IVF/ICSI patients treated with a GnRH antagonist and recombinant FSH with or without pretreatment with an oral contraceptive pill; a randomized controlled study. (RMB Online).
10. Huirne JA and Lambalk CB (2001) Gonadotropin-releasing-hormone-receptor antagonists. Lancet 358,1793-1803.
11. Huirne JA, Van Loenen ACD, Schats R, Mcdonnell J, Hompes PGA, Schoemaker J, Homburg R and Lambalk CB (2004) Dose-finding study of daily gonadotropin-releasing hormone (GnRH) antagonist for the prevention of premature luteinizing hormone surges in IVF/ICSI patients: Antide and hormone levels. Hum Reprod 19,2206-2215.
12. Huirne JA, Van Loenen ACD, Schats R, Mcdonnell J, Hompes PGA, Schoemaker J, Homburg R and Lambalk CB (2005) Dose-finding study of daily gonadotropin-releasing hormone (GnRH) antagonist for the prevention of premature luteinizing hormone surges in IVF/ICSI patients: Optimal changes in LH and progesterone for clinical pregnancy. Hum Reprod 20,359-367.
13. Huirne JA, Van Loenen ACD, Donnez J, Pirand C, Homburg R, Schats R, McDonnell J and Lambalk CB (2006) Follicular development in IVF/ICSI patients treated with a GnRH antagonist and r-hFSH with or without pretreatment with an oral contraceptive pill: An RCT. RBM Online, in press.
14. Hwang JL, Seow KM, Lin YH, Huang LW, Hsieh BC, Tsai YL, Wu GJ, Huang SC, Chen CY, Chen PH et al. (2004) Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: A prospective randomised study. Hum Reprod 19,1993-2004.
15. Kolibianakis EM, Albano C, Camus M, Tournaye H, Van Steirteghem AC and Devroey P (2004) Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril 82,102-107.
16. Kolibianakis EM, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem AC and Devroey P (2006) Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum Reprod 21,352-357.
17. Obruca A, Fischl F and Huber JC (2000) Scheduling OPU in GnRH antagonist cycles. J Reprod Fertil 4,37.
18. Saadat P, Boostanfar R, Slater CC, Tourgeman DE, Stanczyk FZ and Paulson RJ (2004) Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: Impact of gonadotropin-releasing hormone agonists versus antagonists. Fertil Steril 82,167-171.
19. Simon C, Oberye J, Bellver J, Vidal C, Bosch E, Horcajadas JA, Murphy C, Adams S, Riesewijk A, Mannaerts B et al. (2005) Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles. Hum Reprod 20,3318-3327.
20. Templeton A and Morris JK (1998) Reducing the risk of multiple births by transfer of two embryos after in vitro fertilization. N Engl J Med 339, 573-577.
21. van Heusden AM and Fauser BCJM (1999) Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives. Contraception 59,237-243.